Want to join the conversation?
$WAT 2Q15 Q&A: Willoughby of Cleveland had a question regarding pharma demand. Douglas replied that growth is not coming from classical big pharma accounts, which were low single-digits to flat. Most of growth was coming from specialty pharma, generics, big and small biotech accounts, most of which were new volume-based initiatives.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!